Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.935 -0.335 (-6.36%)
Streaming Delayed Price Updated: 11:53 AM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Peering Into Recursion Pharmaceuticals's Recent Short Interest
Via Benzinga
AI-Focused Drug Discovery Stocks Index Up 26% In December
With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions. 
Via Talk Markets
Recursion Pharm Showing Market Leadership As Biotech Stocks Shoot Higher
On Tuesday, Recursion Pharm stock reached a key technical benchmark, seeing its Relative Strength Rating jump to 91 from 88 the day before. 
Via Investor's Business Daily
Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry
Screening libraries will leverage Recursion's MatchMaker tool to identify compounds across Enamine REAL Space predicted to bind to high-value targets. 
From Recursion Pharmaceuticals
Via GlobeNewswire
2 Cathie Wood Stocks That Might Be Smart Buys Right Now
These two biotech stocks hold enormous potential. 
Via The Motley Fool
Looking Into Recursion Pharmaceuticals's Recent Short Interest
Via Benzinga
This Stock Could Soar by 120%, According to Wall Street
Don't rush to buy shares just yet. 
Via The Motley Fool
Recursion Pharmaceuticals: Q3 Earnings Insights
Via Benzinga
3 Genomics Stocks to Unlock the Future of Medicine
Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use. 
Via InvestorPlace
These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest?
2024 is going to be a sizzler in the biopharma sector. 
Via The Motley Fool
AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week
A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method. 
Via Talk Markets
Topics Artificial Intelligence
AI Meets Biotech: 3 Top Stocks Transforming Medical Science
The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology. 
Via InvestorPlace
Topics Artificial Intelligence
Cathie Wood Just Dumped $40 Million of Coinbase Global (COIN) Stock
Wood is moving away from fintech and Internet names like COIN stock. She's now favoring genomics and artificial intelligence companies. 
Via InvestorPlace
Topics Artificial Intelligence
These 9 Micro/Small Cap AI Stocks Continue In Bubble Mode
9 micro/small cap AI stocks are still in bubble mode advancing 14.8%, on average, last week. In comparison, the Global X Artificial Intelligence & Technology ETF was only up 0.5% and the iShares... 
Via Talk Markets
Topics Artificial Intelligence ETFs
The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week
If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to... 
Via Talk Markets
Topics Artificial Intelligence
Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November
The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions. 
Via Talk Markets
Topics Artificial Intelligence
November Recap: Top 9 Micro/Small Cap AI Stocks Up +53%, On Average
The top 9 micro- and small-cap AI stocks advanced by 53%, on average, in November. 
Via Talk Markets
Topics Artificial Intelligence
Hewlett Packard Enterprise Posts Upbeat Earnings, Joins Foot Locker, NetApp And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher, with the Nasdaq Composite gaining around 50 points on Wednesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) moved higher during Wednesday’s session following... 
Via Benzinga
Topics Stocks
Recursion Pharmaceuticals Wants to 4X Its Supercomputing Power for AI With the Help of Nvidia. Here's Why It Matters.
Scaling up means having more power to bring to bear on core activities. 
Via The Motley Fool
Topics Artificial Intelligence
2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth
Small-cap stocks outperform larger companies on an indexed basis, but finding the best among them individually isn't always easy. 
Via InvestorPlace
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The popular growth investor keeps adding to some of her favorite stocks. 
Via The Motley Fool
Cathie Wood Just Made a Big Bet on Recursion Pharmaceuticals Stock. Will It Pay Off?
Cathie Wood just gave the company a huge vote of confidence. 
Via The Motley Fool
Unlocking AI investment opportunities in healthcare
AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities. 
Via MarketBeat
Topics Artificial Intelligence ETFs
Cathie Wood Continues On Roku Shares Selling Spree After Company's Q3 Revenue Jump — Ark Sells $21.1M Of Stock
Via Benzinga
AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence
We’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom that's greatly impacting healthcare. 
Via InvestorPlace
Topics Artificial Intelligence
Bayer and Recursion Focus Research Collaboration on Oncology
Digitally enabled drug discovery for oncology has the potential to accelerate the delivery of new cancer therapies to patients. Drug discovery research collaboration may initiate up to seven oncology... 
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology
With additional patient-centric data, compute power, and an exciting new focus for its Bayer collaboration, the company is accelerating the shift of biotech to techbio 
From Recursion Pharmaceuticals, Inc.
Via GlobeNewswire
Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results
From Recursion Pharmaceuticals
Via GlobeNewswire
3 Stocks to Buy for Their Proximity to Nvidia
Nvidia isn't the only AI stock on the market. These three companies stand to benefit from Nvidia's success while offering diversification. 
Via InvestorPlace
Topics Artificial Intelligence
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Benson Hill, Inc. (NYSE: BHIL) shares jumped 48.1% to $0.3740. 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.